Alnylam Pharmaceuticals Shares Outstanding 2006-2018 | ALNY

Alnylam Pharmaceuticals shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Alnylam Pharmaceuticals shares outstanding for the quarter ending September 30, 2018 were 0.101B, a 9.75% increase year-over-year.
  • Alnylam Pharmaceuticals 2017 shares outstanding were 0.091B, a 5.79% increase from 2016.
  • Alnylam Pharmaceuticals 2016 shares outstanding were 0.086B, a 1.91% increase from 2015.
  • Alnylam Pharmaceuticals 2015 shares outstanding were 0.084B, a 13.08% increase from 2014.
Alnylam Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 91
2016 86
2015 84
2014 74
2013 62
2012 50
2011 42
2010 42
2009 42
2008 41
2007 39
2006 32
2005 22
Alnylam Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 101
Q2 2018 101
Q1 2018 100
Q4 2017 91
Q3 2017 92
Q2 2017 88
Q1 2017 86
Q4 2016 86
Q3 2016 86
Q2 2016 86
Q1 2016 85
Q4 2015 84
Q3 2015 85
Q2 2015 84
Q1 2015 82
Q4 2014 74
Q3 2014 76
Q2 2014 76
Q1 2014 68
Q4 2013 62
Q3 2013 62
Q2 2013 62
Q1 2013 59
Q4 2012 50
Q3 2012 52
Q2 2012 51
Q1 2012 46
Q4 2011 42
Q3 2011 43
Q2 2011 42
Q1 2011 42
Q4 2010 42
Q3 2010 42
Q2 2010 42
Q1 2010 42
Q4 2009 42
Q3 2009 42
Q2 2009 42
Q1 2009 41
Q4 2008 41
Q3 2008 41
Q2 2008 41
Q1 2008 41
Q4 2007 39
Q3 2007 39
Q2 2007 38
Q1 2007 37
Q4 2006 32
Q3 2006 32
Q2 2006 32
Q1 2006 30
Q4 2005 22
Q3 2005 21
Q2 2005 21
Q1 2005 20
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.316B $0.090B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.085B 13.92
Gilead Sciences (GILD) United States $92.080B 11.09
Biogen (BIIB) United States $65.522B 13.27
Celgene (CELG) United States $51.759B 10.04
Illumina (ILMN) United States $48.400B 56.38
Vertex Pharmaceuticals (VRTX) United States $46.141B 80.60
Regeneron Pharmaceuticals (REGN) United States $38.539B 19.55
Alexion Pharmaceuticals (ALXN) United States $27.539B 18.85
BioMarin Pharmaceutical (BMRN) United States $17.035B 0.00
Incyte (INCY) United States $14.052B 388.41
Seattle Genetics (SGEN) United States $9.298B 0.00
Exact Sciences (EXAS) United States $9.171B 0.00
Sarepta Therapeutics (SRPT) United States $8.384B 0.00
QIAGEN (QGEN) Netherlands $8.210B 26.25
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
Bluebird Bio (BLUE) United States $6.910B 0.00
BeiGene (BGNE) Cayman Islands $6.519B 0.00
Bio-Techne Corp (TECH) United States $6.450B 43.57
Amarin (AMRN) Ireland $6.153B 0.00
Alkermes (ALKS) Ireland $5.853B 3767.00
Galapagos (GLPG) Belgium $5.430B 0.00
Exelixis (EXEL) United States $4.984B 14.13
Immunomedics (IMMU) United States $4.079B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.787B 0.00
Horizon Pharma Public (HZNP) Ireland $3.736B 15.37
Array BioPharma (ARRY) United States $3.565B 0.00
Allogene Therapeutics (ALLO) United States $3.528B 0.00
Emergent Biosolutions (EBS) United States $3.441B 28.99
Ligand Pharmaceuticals (LGND) United States $3.347B 25.79
Intercept Pharmaceuticals (ICPT) United States $3.227B 0.00
Guardant Health (GH) United States $3.184B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.131B 0.00
Repligen (RGEN) United States $2.971B 92.79
Genomic Health (GHDX) United States $2.928B 99.60
Ascendis Pharma (ASND) Denmark $2.664B 0.00
Blueprint Medicines (BPMC) United States $2.643B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.642B 0.00
Acceleron Pharma (XLRN) United States $2.535B 0.00
REGENXBIO (RGNX) United States $2.379B 31.91
ACADIA Pharmaceuticals (ACAD) United States $2.359B 0.00
MyoKardia (MYOK) United States $2.333B 0.00
Myriad Genetics (MYGN) United States $2.306B 22.85
Halozyme Therapeutics (HALO) United States $2.297B 51.26
China Biologic Products (CBPO) China $2.294B 16.33
Akcea Therapeutics (AKCA) United States $2.274B 0.00
Allakos (ALLK) United States $2.239B 0.00
Global Blood Therapeutics (GBT) United States $2.084B 0.00
Amicus Therapeutics (FOLD) United States $2.005B 0.00
Reata Pharmaceuticals (RETA) United States $1.952B 0.00
AnaptysBio (ANAB) United States $1.935B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.887B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.862B 0.00
Arena Pharmaceuticals (ARNA) United States $1.792B 0.00
Aimmune Therapeutics (AIMT) United States $1.779B 0.00
Medicines (MDCO) United States $1.757B 0.00
Cambrex (CBM) United States $1.719B 12.84
G1 THERAPEUTICS (GTHX) United States $1.698B 0.00
Innoviva (INVA) United States $1.656B 9.37
Atara Biotherapeutics (ATRA) United States $1.654B 0.00
Spark Therapeutics (ONCE) United States $1.614B 0.00
Denali Therapeutics (DNLI) United States $1.584B 0.00
NeoGenomics (NEO) United States $1.578B 130.54
Biohaven Pharmaceutical Holding (BHVN) United States $1.562B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.436B 0.00
Editas Medicine (EDIT) United States $1.384B 0.00
Myovant Sciences (MYOV) United Kingdom $1.300B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Mirati Therapeutics (MRTX) United States $1.286B 0.00
WAVE Life Sciences (WVE) Singapore $1.266B 0.00
Insmed (INSM) United States $1.261B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.249B 99.21
Rubius Therapeutics (RUBY) United States $1.240B 0.00
Sangamo Therapeutics (SGMO) United States $1.134B 0.00
Cellectis (CLLS) France $1.103B 0.00
DBV Technologies (DBVT) France $1.095B 0.00
Solid Biosciences (SLDB) United States $1.075B 0.00
Retrophin (RTRX) United States $1.063B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.030B 0.00
Audentes Therapeutics (BOLD) United States $1.025B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.003B 0.00
Intra-Cellular Therapies (ITCI) United States $0.990B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.986B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.983B 0.00
UniQure (QURE) Netherlands $0.959B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.950B 0.00
Acorda Therapeutics (ACOR) United States $0.949B 12.02
Alder BioPharmaceuticals (ALDR) United States $0.948B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.923B 0.00
Puma Biotechnology (PBYI) United States $0.891B 0.00
Viking Therapeutics (VKTX) United States $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.868B 0.00
Aptinyx (APTX) United States $0.867B 0.00
Lion Biotechnologies (IOVA) United States $0.857B 0.00
Apellis Pharmaceuticals (APLS) United States $0.834B 0.00
Fate Therapeutics (FATE) United States $0.827B 0.00
Clovis Oncology (CLVS) United States $0.825B 0.00
Intellia Therapeutics (NTLA) United States $0.815B 0.00
Athenex (ATNX) United States $0.808B 0.00
Heska (HSKA) United States $0.782B 63.97
Cara Therapeutics (CARA) United States $0.773B 0.00
InflaRx (IFRX) Germany $0.760B 0.00
Dynavax Technologies (DVAX) United States $0.758B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.753B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.739B 0.00
Mesoblast (MESO) Australia $0.714B 0.00
Vericel (VCEL) United States $0.698B 0.00
Novavax (NVAX) United States $0.685B 0.00
Coherus BioSciences (CHRS) United States $0.684B 0.00
AVROBIO (AVRO) United States $0.684B 0.00
Gritstone Oncology (GRTS) United States $0.680B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.677B 0.00
CytomX Therapeutics (CTMX) United States $0.675B 0.00
UROGEN PHARMA (URGN) Israel $0.642B 0.00
Scholar Rock Holding (SRRK) United States $0.631B 0.00
ANI Pharmaceuticals (ANIP) United States $0.623B 11.94
AMAG Pharmaceuticals (AMAG) United States $0.616B 0.00
Epizyme (EPZM) United States $0.614B 0.00
Senesco Technologies (ELOX) United States $0.599B 0.00
Arvinas (ARVN) United States $0.592B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.583B 0.00
AC Immune SA (ACIU) Switzerland $0.575B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.575B 0.00
Principia Biopharma (PRNB) United States $0.566B 0.00
ObsEva SA (OBSV) Switzerland $0.559B 0.00
Arcus Biosciences (RCUS) United States $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.543B 22.49
UNITY Biotechnology (UBX) $0.504B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Inovio Pharmaceuticals (INO) United States $0.484B 0.00
Kezar Life Sciences (KZR) United States $0.470B 0.00
Eidos Therapeutics (EIDX) United States $0.467B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.456B 0.00
Kura Oncology (KURA) United States $0.456B 0.00
Replimune (REPL) United States $0.455B 0.00
Kindred Biosciences (KIN) United States $0.454B 0.00
BeyondSpring (BYSI) United States $0.453B 0.00
Abeona Therapeutics (ABEO) United States $0.449B 0.00
Zymeworks (ZYME) Canada $0.441B 0.00
Sinovac Biotech (SVA) China $0.438B 0.00
MediciNova (MNOV) United States $0.434B 0.00
Sorrento Therapeutics (SRNE) United States $0.428B 73.40
Zealand Pharma (ZEAL) Denmark $0.427B 0.00
Stemline Therapeutics (STML) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.417B 6.81
Five Prime Therapeutics (FPRX) United States $0.410B 0.00
Verastem (VSTM) United States $0.406B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.396B 0.00
Cytokineticsorporated (CYTK) United States $0.389B 0.00
RA PHARMCTL INC (RARX) United States $0.388B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.350B 0.00
Seres Therapeutics (MCRB) United States $0.343B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.332B 0.00
LogicBio Therapeutics (LOGC) United States $0.331B 0.00
Krystal Biotech (KRYS) United States $0.322B 0.00
ResTORbio (TORC) United States $0.319B 0.00
Kodiak Sciences (KOD) United States $0.316B 0.00
Merus (MRUS) Netherlands $0.311B 0.00
Albireo Pharma (ALBO) United States $0.309B 0.00
Geron (GERN) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
Sutro Biopharma (STRO) United States $0.306B 0.00
Kadmon Holdings (KDMN) United States $0.299B 0.00
Liquidia Technologies (LQDA) United States $0.295B 0.00
MannKind (MNKD) United States $0.292B 0.00
Aduro Biotech (ADRO) United States $0.288B 0.00
Magenta Therapeutics (MGTA) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.288B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.281B 0.00
Celcuity (CELC) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.276B 0.00
Equillium (EQ) United States $0.276B 0.00
Strongbridge Biopharma (SBBP) United States $0.272B 0.00
BioDelivery Sciences (BDSI) United States $0.267B 0.00
Athersys (ATHX) United States $0.265B 0.00
TOCAGEN INC (TOCA) United States $0.261B 0.00
Arbutus Biopharma (ABUS) Canada $0.258B 0.00
Proteostasis Therapeutics (PTI) United States $0.258B 0.00
Evelo Biosciences (EVLO) United States $0.255B 0.00
Axovant Sciences (AXON) United Kingdom $0.254B 0.00
Syros Pharmaceuticals (SYRS) United States $0.248B 0.00
ADMA Biologics Inc (ADMA) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.243B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.239B 0.00
Agenus (AGEN) United States $0.239B 0.00
Adverum Biotechnologies (ADVM) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.235B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.232B 0.00
Urovant Sciences (UROV) United States $0.231B 0.00
Idera Pharmaceuticals (IDRA) United States $0.228B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.218B 0.00
NantKwest (NK) United States $0.218B 0.00
Kamada (KMDA) Israel $0.215B 16.69
Unum Therapeutics (UMRX) United States $0.215B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.212B 0.00
Synlogic (SYBX) United States $0.203B 0.00
ChromaDex (CDXC) United States $0.200B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.199B 0.00
Intec Pharma (NTEC) Israel $0.193B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.193B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.184B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.182B 0.00
Cerecor (CERC) United States $0.177B 18.13
PSivida (EYPT) United States $0.171B 0.00
Compugen (CGEN) Israel $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Allena Pharmaceuticals (ALNA) United States $0.168B 0.00
Cohbar (CWBR) United States $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.156B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Constellation Pharmaceuticals (CNST) United States $0.151B 0.00
Cue Biopharma (CUE) United States $0.144B 0.00
Mustang Bio (MBIO) United States $0.143B 0.00
Mersana Therapeutics (MRSN) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.138B 0.00
XBiotech (XBIT) United States $0.138B 0.00
Eleven Biotherapeutics (SESN) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.138B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.135B 0.00
Organovo Holdings (ONVO) United States $0.132B 0.00
VBI Vaccines (VBIV) United States $0.132B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.124B 0.00
Applied Genetic Technologies (AGTC) United States $0.121B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.121B 0.00
Signal Genetics (MGEN) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.119B 0.00
Anavex Life Sciences (AVXL) United States $0.119B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
Cidara Therapeutics (CDTX) United States $0.112B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Provention Bio (PRVB) United States $0.107B 0.00
Axsome Therapeutics (AXSM) United States $0.102B 0.00
Chiasma (CHMA) United States $0.100B 0.00
Monster Digital (INNT) United States $0.100B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
BioXcel Therapeutics (BTAI) United States $0.092B 0.00
Ophthotech (OPHT) United States $0.092B 0.00
Orgenesis (ORGS) United States $0.092B 0.00
VTv Therapeutics (VTVT) United States $0.091B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Prima BioMed (IMMP) Australia $0.088B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.087B 0.00
Checkpoint Therapeutics (CKPT) United States $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.077B 0.00
Aptevo Therapeutics (APVO) United States $0.076B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Alcobra (ARCT) United States $0.075B 0.00
ITUS (ANIX) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Celldex Therapeutics (CLDX) United States $0.063B 0.00
Bellerophon Therapeutics (BLPH) United States $0.062B 0.00
VistaGen Therapeutics (VTGN) United States $0.062B 0.00
Sophiris Bio (SPHS) United States $0.062B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.061B 9.94
Leap Therapeutics (LPTX) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Fortress Biotech (FBIO) United States $0.060B 0.00
Clearside Biomedical (CLSD) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Cocrystal Pharma (COCP) United States $0.055B 0.00
Trevena (TRVN) United States $0.054B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
OncoSec Medical (ONCS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
TRACON Pharmaceuticals (TCON) United States $0.043B 0.00
Versartis (ARAV) United States $0.042B 6.89
AquaBounty Technologies (AQB) United States $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
VIVUS (VVUS) United States $0.039B 0.00
GTx (GTXI) United States $0.037B 0.00
AEterna Zentaris (AEZS) United States $0.037B 7.06
Moleculin Biotech (MBRX) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Galena Biopharma (SLS) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.033B 0.00
Novelion Therapeutics (NVLN) Canada $0.032B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Vical (VICL) United States $0.029B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.62
CytRx (CYTR) United States $0.027B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Cellect Biotechnology (APOP) Israel $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.024B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Arsanis (ASNS) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.015B 0.00
Histogenics (HSGX) United States $0.015B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Adial Pharmaceuticals (ADIL) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00